Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial
- DOI
- 10.1038/bonekey.2016.72
- Published
- 2016-10-19
- Container
- BoneKEy Reports
- Publisher
- Portico
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/bonekey.2016.72,
title = {Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial},
author = {Huifang Lu and Richard E Champlin and Uday Popat and Xerxes Pundole and Carmelita P Escalante and Xuemei Wang and Wei Qiao and William A Murphy and Robert F Gagel},
year = {2016},
journal = {BoneKEy Reports},
doi = {10.1038/bonekey.2016.72},
url = {https://doi.org/10.1038/bonekey.2016.72}
}RIS
TY - JOUR TI - Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial AU - Huifang Lu AU - Richard E Champlin AU - Uday Popat AU - Xerxes Pundole AU - Carmelita P Escalante AU - Xuemei Wang AU - Wei Qiao AU - William A Murphy AU - Robert F Gagel PY - 2016 JO - BoneKEy Reports DO - 10.1038/bonekey.2016.72 UR - https://doi.org/10.1038/bonekey.2016.72 ER -
APA
Lu, H., Champlin, R. E., Popat, U., Pundole, X., Escalante, C. P., Wang, X., Qiao, W., Murphy, W. A., & Gagel, R. F. (2016). Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial. BoneKEy Reports. https://doi.org/10.1038/bonekey.2016.72
Source records
- crossref · retrieved 2026-11-04T23:37:33.557Z